CHM 5.56% 1.9¢ chimeric therapeutics limited

Ann: CDH17 CAR T PRECLINICAL DATA FEATURED IN NATURE CANCER, page-15

  1. 387 Posts.
    lightbulb Created with Sketch. 76
    Can anyone here mentioning acquisitions just please stop. Like this group is 4 years away from that at minimum. They will develop their assets through to end of phase 2, have a market cap of 1-2billion and only then will they start negotiating with big pharma for a buyout.. Just hold the fkn line and load up while it's cheap lmao
    Last edited by shemara: 23/03/22
 
watchlist Created with Sketch. Add CHM (ASX) to my watchlist
(20min delay)
Last
1.9¢
Change
0.001(5.56%)
Mkt cap ! $15.76M
Open High Low Value Volume
1.9¢ 1.9¢ 1.9¢ $12.29K 648.9K

Buyers (Bids)

No. Vol. Price($)
1 12983 1.9¢
 

Sellers (Offers)

Price($) Vol. No.
2.0¢ 1432067 5
View Market Depth
Last trade - 10.24am 04/07/2024 (20 minute delay) ?
CHM (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.